Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.

One of a series of Wellcome Trust reviews of the active ingredients of interventions to prevent/treat depression and anxiety in young people was carried out by the team in the Psychopharmacology and Emotion Research Laboratory (PERL) at the Department of Psychiatry, University of Oxford. They reviewed the literature about the use of antidepressants in young people aged 14-24 years, and held a series of online workshops with young people with lived experience, which were supported by the McPin Foundation and the NEUROSEC (Neuroscience, Ethics and Society) Young People Advisory Group. 

Dr Susie Murphy, Department of Psychiatry, said,

There is understandable disquiet about the use of antidepressants in young people and yet there are also significant risks associated with under-treating severe depression in this age group. It is important to understand the effects antidepressants have in young people so that they can make informed choices about the best treatment approach for them. 

A recent blog - Antidepressants and psychotherapy for adolescent depression: can they be compared? #ActiveIngredientsMH.

A new animation created with contributions from young people with lived experience from the McPin Foundation and NEUROSEC - Antidepressants for young people with depression and anxiety.

 

 

Listen to a podcast with Professor Catherine Harmer and Dr Susie Murphy discussing the knowns and unknowns of antidepressant effects in young people with the Mental Elf.

For more information about the work of PERL.

Similar stories

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

New Study Shows Simvastatin Can Change the Way People Experience Certain Emotions

This new study examines the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation.

Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment

A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.